HIV incidence determination in the United States: a multiassay approach.

BACKGROUND Accurate testing algorithms are needed for estimating human immunodeficiency virus (HIV) incidence from cross-sectional surveys. METHODS We developed a multiassay algorithm (MAA) for HIV incidence that includes the BED capture enzyme immunoassay (BED-CEIA), an antibody avidity assay, HIV load, and CD4(+) T-cell count. We analyzed 1782 samples from 709 individuals in the United States who had a known duration of HIV infection (range, 0 to >8 years). Logistic regression with cubic splines was used to compare the performance of the MAA to the BED-CEIA and to determine the window period of the MAA. We compared the annual incidence estimated with the MAA to the annual incidence based on HIV seroconversion in a longitudinal cohort. RESULTS The MAA had a window period of 141 days (95% confidence interval [CI], 94-150) and a very low false-recent misclassification rate (only 0.4% of 1474 samples from subjects infected for >1 year were misclassified as indicative of recent infection). In a cohort study, annual incidence based on HIV seroconversion was 1.04% (95% CI, .70%-1.55%). The incidence estimate obtained using the MAA was essentially identical: 0.97% (95% CI, .51%-1.71%). CONCLUSIONS The MAA is as sensitive for detecting recent HIV infection as the BED-CEIA and has a very low rate of false-recent misclassification. It provides a powerful tool for cross-sectional HIV incidence determination.

[1]  Susan A. Murphy,et al.  Monographs on statistics and applied probability , 1990 .

[2]  Richard D Moore,et al.  Use of a High Resolution Melting (HRM) Assay to Compare Gag, Pol, and Env Diversity in Adults with Different Stages of HIV Infection , 2011, PloS one.

[3]  J. Kaldor,et al.  Accuracy of serological assays for detection of recent infection with HIV and estimation of population incidence: a systematic review. , 2009, The Lancet. Infectious diseases.

[4]  J. Margolick,et al.  Factors associated with incorrect identification of recent HIV infection using the BED capture immunoassay. , 2012, AIDS research and human retroviruses.

[5]  Ekkehard Kopp,et al.  Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay , 2008, AIDS.

[6]  Oliver Laeyendecker,et al.  Estimating HIV Incidence in Populations Using Tests for Recent Infection: Issues, Challenges and the Way Forward. , 2010, Journal of HIV AIDS surveillance & epidemiology.

[7]  M. Goldman.  New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes , 1999 .

[8]  L. Tavoschi,et al.  Detection of recent HIV infections in African individuals infected by HIV-1 non-B subtypes using HIV antibody avidity. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[9]  R Brookmeyer,et al.  Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests. , 1995, American journal of epidemiology.

[10]  J. Margolick,et al.  HIV-1 variation before seroconversion in men who have sex with men: analysis of acute/early HIV infection in the multicenter AIDS cohort study. , 2008, The Journal of infectious diseases.

[11]  J. Stockman.  Estimation of HIV incidence in the United States , 2010 .

[12]  Ruiguang Song,et al.  Estimated HIV Incidence in the United States, 2006–2009 , 2011, PloS one.

[13]  J. Phair,et al.  The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. , 1987, American journal of epidemiology.

[14]  R. Brookmeyer,et al.  The AIDS epidemic in India: a new method for estimating current human immunodeficiency virus (HIV) incidence rates. , 1995, American journal of epidemiology.

[15]  P. Ghys,et al.  Global trends in molecular epidemiology of HIV-1 during 2000–2007 , 2011, AIDS.

[16]  T. Hallett,et al.  A Decline in New HIV Infections in South Africa: Estimating HIV Incidence from Three National HIV Surveys in 2002, 2005 and 2008 , 2010, PloS one.

[17]  R. Brookmeyer,et al.  Specificity of four laboratory approaches for cross-sectional HIV incidence determination: analysis of samples from adults with known nonrecent HIV infection from five African countries. , 2012, AIDS research and human retroviruses.

[18]  R. Brookmeyer.  Accounting for Follow‐up Bias in Estimation of Human Immunodeficiency Virus Incidence Rates , 1997 .

[19]  J. Margolick,et al.  Anti-HIV type 1 memory cytotoxic T lymphocyte responses associated with changes in CD4+ T cell numbers in progression of HIV type 1 infection. , 1998, AIDS research and human retroviruses.

[20]  J. Hargrove.  BED estimates of HIV incidence must be adjusted. , 2009, AIDS.

[21]  S. Self,et al.  Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study. , 2001, American journal of epidemiology.

[22]  A. Trkola,et al.  Humoral immunity to HIV-1: kinetics of antibody responses in chronic infection reflects capacity of immune system to improve viral set point. , 2004, Blood.

[23]  G A Satten,et al.  New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. , 1998, JAMA.

[24]  O. Laeyendecker,et al.  The Effect of Viral Suppression on Cross-Sectional Incidence Testing in the Johns Hopkins Hospital Emergency Department , 2008, Journal of acquired immune deficiency syndromes.

[25]  S. Oka,et al.  Effects of low HIV type 1 load and antiretroviral treatment on IgG-capture BED-enzyme immunoassay. , 2008, AIDS research and human retroviruses.

[26]  Robert Tibshirani,et al.  An Introduction to the Bootstrap , 1994 .

[27]  S. Buchbinder,et al.  Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus load. , 2001, The Journal of infectious diseases.

[28]  Alex Welte,et al.  Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation. , 2010, AIDS.

[29]  R. Brookmeyer.  On the Statistical Accuracy of Biomarker Assays for HIV Incidence , 2010, Journal of acquired immune deficiency syndromes.

[30]  T. Bärnighausen,et al.  Reply to 'Should biomarker estimates of HIV incidence be adjusted?'. , 2009, AIDS.

[31]  R. Janssen,et al.  Development of a new less-sensitive enzyme immunoassay for detection of early HIV-1 infection. , 2003, Journal of acquired immune deficiency syndromes.

[32]  O. Laeyendecker,et al.  Can HIV incidence testing be used for evaluating HIV intervention programs? A reanalysis of the Orange Farm male circumcision trial (ANRS-1265) , 2010, BMC infectious diseases.

[33]  Edward H. Kaplan,et al.  Snapshot Estimators of Recent HIV Incidence Rates , 1999, Oper. Res..

[34]  A Munoz,et al.  The Alive Study: A Longitudinal Study of HIV-1 Infection in Intravenous Drug Users: Description of Methods , 1991, NIDA research monograph.

[35]  J. Parry,et al.  Assays for the detection of recent infections with human immunodeficiency virus type 1. , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[36]  C. Pau,et al.  Performance Characteristics of the Immunoglobulin G-Capture BED-Enzyme Immunoassay, an Assay To Detect Recent Human Immunodeficiency Virus Type 1 Seroconversion , 2004, Journal of Clinical Microbiology.

[37]  Ron Brookmeyer,et al.  Measuring the HIV/AIDS epidemic: approaches and challenges. , 2010, Epidemiologic reviews.

[38]  F. Ketema,et al.  A simple and inexpensive particle agglutination test to distinguish recent from established HIV-1 infection. , 2007, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[39]  J. Parry,et al.  The Effect of Sample Handling on Cross Sectional HIV Incidence Testing Results , 2011, PloS one.

[40]  Gonzalo Domingo,et al.  More and Better Information to Tackle HIV Epidemics: Towards Improved HIV Incidence Assays , 2011, PLoS medicine.

[41]  Bernard Branson,et al.  Determination of mean recency period for estimation of HIV type 1 Incidence with the BED-capture EIA in persons infected with diverse subtypes. , 2011, AIDS research and human retroviruses.

[42]  J. Margolick,et al.  Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline. , 1998, Proceedings of the National Academy of Sciences of the United States of America.